- Home
- ATNM vs BMR Comparison
ATNM vs BMR Comparison
Compare ATNM & BMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNM
- BMR
- Stock Information
- Founded
- ATNM 2000
- BMR 2009
- Country
- ATNM United States
- BMR Israel
- Employees
- ATNM N/A
- BMR N/A
- Industry
- ATNM Biotechnology: Pharmaceutical Preparations
- BMR Computer Software: Prepackaged Software
- Sector
- ATNM Health Care
- BMR Technology
- Exchange
- ATNM Nasdaq
- BMR Nasdaq
- Market Cap
- ATNM 50.2M
- BMR 41.9M
- IPO Year
- ATNM N/A
- BMR 2023
- Fundamental
- Price
- ATNM $1.61
- BMR $2.87
- Analyst Decision
- ATNM Strong Buy
- BMR
- Analyst Count
- ATNM 2
- BMR 0
- Target Price
- ATNM $4.50
- BMR N/A
- AVG Volume (30 Days)
- ATNM 122.2K
- BMR 875.5K
- Earning Date
- ATNM 11-13-2025
- BMR 08-13-2025
- Dividend Yield
- ATNM N/A
- BMR N/A
- EPS Growth
- ATNM N/A
- BMR N/A
- EPS
- ATNM N/A
- BMR N/A
- Revenue
- ATNM N/A
- BMR $3,131,000.00
- Revenue This Year
- ATNM N/A
- BMR $21.21
- Revenue Next Year
- ATNM N/A
- BMR N/A
- P/E Ratio
- ATNM N/A
- BMR N/A
- Revenue Growth
- ATNM N/A
- BMR 5.96
- 52 Week Low
- ATNM $1.03
- BMR $1.86
- 52 Week High
- ATNM $2.41
- BMR $6.59
- Technical
- Relative Strength Index (RSI)
- ATNM 45.72
- BMR 47.56
- Support Level
- ATNM $1.60
- BMR $2.78
- Resistance Level
- ATNM $1.70
- BMR $2.96
- Average True Range (ATR)
- ATNM 0.07
- BMR 0.17
- MACD
- ATNM -0.01
- BMR 0.02
- Stochastic Oscillator
- ATNM 32.14
- BMR 45.76
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About BMR Beamr Imaging Ltd.
Beamr Imaging Ltd is a video technology and image science software company. It is an innovator of video encoding, transcoding, and optimization solutions that enable high quality, performance, and unmatched bitrate efficiency for video and images. The company is conducted through one operating segment, the optimization technology for video and photo compression. The company operates in Israel, the United States, and the rest of the world, it derives a majority of its revenue from the United States.